Healthy clocks, healthy body, healthy mind

Trends in Cell Biology

Volumn 20, Issue 1, 2010, Pages 36-44

  Reddy, Akhilesh B ^a   O'Neill, John S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOCHROME; CRYPTOCHROME 2; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; ROSCOVITINE; SIRTUIN 1; TRANSCRIPTION FACTOR CLOCK;

AGING; ALZHEIMER DISEASE; BIOLOGICAL RHYTHM; CELL CYCLE; CELL PROLIFERATION; CHRONOTHERAPY; CIRCADIAN RHYTHM; COLORECTAL CANCER; EVENING DOSAGE; GENE EXPRESSION; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; MOLECULAR DYNAMICS; MORNING DOSAGE; NEOPLASM; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; TUMOR SUPPRESSOR GENE;

AGING; ANIMALS; CELL CYCLE; CIRCADIAN RHYTHM; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 72549118386     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2009.10.005     Document Type: Review

References (122)

1. Dunlap J.C. Molecular bases for circadian clocks. Cell 96 (1999) 271-290
2. Takahashi J.S., et al. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat. Rev. Genet. 9 (2008) 764-775
3. Kohsaka A., and Bass J. A sense of time: how molecular clocks organize metabolism. Trends Endocrinol. Metab. 18 (2007) 4-11
4. Woelfle M.A., et al. The adaptive value of circadian clocks; an experimental assessment in cyanobacteria. Curr. Biol. 14 (2004) 1481-1486
5. Dodd A.N., et al. Plant circadian clocks increase photosynthesis, growth, survival, and competitive advantage. Science 309 (2005) 630-633
6. Barger L.K., et al. Neurobehavioral, health, and safety consequences associated with shift work in safety-sensitive professions. Curr. Neurol. Neurosci. Rep. 9 (2009) 155-164
7. Preuss F., et al. Adverse effects of chronic circadian desynchronization in animals in a 'challenging' environment. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 (2008) R2034-2040
8. Kondratov R.V., and Antoch M.P. The clock proteins, aging, and tumorigenesis. Cold Spring Harb. Symp. Quant. Biol. 72 (2007) 477-482
9. Nagoshi E., et al. Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 119 (2004) 693-705
10. Mullenders J., et al. A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PLoS One 4 (2009) e4798
11. Filipski E., et al. Disruption of circadian coordination and malignant growth. Cancer Causes Control 17 (2006) 509-514
12. Gibson E.M., et al. Aging in the circadian system: considerations for health, disease prevention and longevity. Exp. Geronto.l 44 (2009) 51-56
13. Reilly T., et al. Jet lag and air travel: implications for performance. Clin. Sports Med. 24 (2005) 367-380 xii
14. Schmidt C., et al. A time to think: circadian rhythms in human cognition. Cogn. Neuropsychol. 24 (2007) 755-789
15. Levi F., and Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 593-628
16. Hu K., et al. The endogenous circadian pacemaker imparts a scale-invariant pattern of heart rate fluctuations across time scales spanning minutes to 24 hours. J. Biol. Rhythms 23 (2008) 265-273
17. Habbal O.A., and Al-Jabri A.A. Circadian rhythm and the immune response: a review. Int. Rev. Immunol. 28 (2009) 93-108
18. Portaluppi F., and Lemmer B. Chronobiology and chronotherapy of ischemic heart disease. Adv. Drug. Deliv. Rev. 59 (2007) 952-965
19. Wirz-Justice A. Diurnal variation of depressive symptoms. Dialogues Clin. Neurosci. 10 (2008) 337-343
20. Reddy A.B., et al. Circadian orchestration of the hepatic proteome. Curr. Biol. 16 (2006) 1107-1115
21. Costa G. The impact of shift and night work on health. Applied Ergonomics 27 (1996) 9-16
22. Brown D.L., et al. Rotating night shift work and the risk of ischemic stroke. Am. J. Epidemiol. 169 (2009) 1370-1377
23. Schernhammer E.S., et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J. Natl. Cancer. Inst. 93 (2001) 1563-1568
24. Schernhammer E.S., et al. Night work and risk of breast cancer. Epidemiology 17 (2006) 108-111
25. Wise J. Danish night shift workers with breast cancer awarded compensation. Br. Med. J. 338 (2009) b1152
26. Reiter R.J., et al. Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. Crit. Rev. Oncog. 13 (2007) 303-328
27. Scheer F.A., et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. U. S. A 106 (2009) 4453-4458
28. Muck W., et al. Pharmacokinetics of cerivastatin when administered under fasted and fed conditions in the morning or evening. Int. J. Clin. Pharmacol. Ther. 38 (2000) 298-303
29. Arble D.M., et al. Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring) 17 (2009) 2100-2102
30. Hastings M.H., et al. Analysis of circadian mechanisms in the suprachiasmatic nucleus by transgenesis and biolistic transfection. Methods Enzymol. 393 (2005) 579-592
31. Weaver D.R. The suprachiasmatic nucleus: a 25-year retrospective. J. Biol. Rhythms 13 (1998) 100-112
32. Hastings M.H., et al. Two decades of circadian time. J. Neuroendocrinol. 20 (2008) 812-819
33. Guler A.D., et al. Multiple photoreceptors contribute to nonimage-forming visual functions predominantly through melanopsin-containing retinal ganglion cells. Cold Spring Harb. Symp. Quant. Biol. 72 (2007) 509-515
34. Akhtar R.A., et al. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr. Biol. 12 (2002) 540-550
35. Yoo S.H., et al. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5339-5346
36. Harmar A.J., et al. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 109 (2002) 497-508
37. Busino L., et al. SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science 316 (2007) 900-904
38. Godinho S.I., et al. The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period. Science 316 (2007) 897-900
39. Siepka S.M., et al. Circadian mutant Overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell 129 (2007) 1011-1023
40. Lowrey P.L., et al. Positional syntenic cloning and functional characterisation of the mammalian circadian mutation tau. Science 288 (2000) 483-491
41. Maywood E.S., et al. Genetic and molecular analysis of the central and peripheral circadian clockwork of mice. Cold Spring Harb. Symp. Quant. Biol. 72 (2007) 85-94
42. Reppert S.M., and Weaver D.R. Coordination of circadian timing in mammals. Nature 418 (2002) 935-941
43. Kornmann B., et al. System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol 5 (2007) e34
44. Reddy A.B., and Maywood E.S. Circadian rhythms: per2bations in the liver clock. Curr. Biol. 17 (2007) R292-294
45. Reddy A.B., et al. Glucocorticoid signaling synchronizes the liver circadian transcriptome. Hepatology 45 (2007) 1478-1488
46. Balsalobre A., et al. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289 (2000) 2344-2347
47. Balsalobre A., et al. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93 (1998) 929-937
48. Balsalobre A., et al. Multiple signaling pathways elicit circadian gene expression in cultured rat-1 fibroblasts. Curr. Biol. 10 (2000) 1291-1294
49. Brown S.A., et al. Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr. Biol. 12 (2002) 1574-1583
50. Mohawk J.A., et al. The methamphetamine-sensitive circadian oscillator does not employ canonical clock genes. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 3519-3524
51. Storch K.F., and Weitz C.J. Daily rhythms of food-anticipatory behavioral activity do not require the known circadian clock. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 6808-6813
52. Bozek K., et al. Regulation of clock-controlled genes in mammals. PLoS One 4 (2009) e4882
53. Ukai-Tadenuma M., et al. Proof-by-synthesis of the transcriptional logic of mammalian circadian clocks. Nat. Cell. Biol. 10 (2008) 1154-1163
54. Lamia K.A., et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science 326 (2009) 437-440
55. O'Neill J.S., et al. cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 320 (2008) 949-953
56. Eckel-Mahan K., and Sassone-Corsi P. Metabolism control by the circadian clock and vice versa. Nat. Struct. Mol. Biol. 16 (2009) 462-467
57. Clausen O.P., et al. Circadian rhythms in mouse epidermal basal cell proliferation. Variations in compartment size, flux and phase duration. Cell Tissue Kinet. 12 (1979) 319-337
58. Rensing L., and Goedeke K. Circadian rhythm and cell cycle: possible entraining mechanisms. Chronobiologia 3 (1976) 853-865
59. Scheving L.E., and Pauly J.E. Cellular mechanism involving biorhythms with emphasis on those rhythms associated with the S and M stages of the cell cycle. Int. J. Chronobiol. 1 (1973) 269-286
60. Gushchin V.A. [Relation of the duration of phases S and M of the cell cycle, the labelling index and the mitotic index in order to sustain circadian rhythm]. Tsitologiia 13 (1971) 1035-1038
61. Hunt T., and Sassone-Corsi P. Riding tandem: circadian clocks and the cell cycle. Cell 129 (2007) 461-464
62. Reddy A.B., et al. Circadian clocks: neural and peripheral pacemakers that impact upon the cell division cycle. Mutat. Res. 574 (2005) 76-91
63. Borgs L., et al. Cell 'circadian' cycle: new role for mammalian core clock genes. Cell Cycle 8 (2009) 832-837
64. Matsuo T., et al. Control mechanism of the circadian clock for timing of cell division in vivo. Science 302 (2003) 255-259
65. Levi F., et al. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Philos. Trans. R. Soc. Lond. A Math. Phys. Sci. 366 (2008) 3575-3598
66. Fu L., et al. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111 (2002) 41-50
67. Lee C.C. Tumor suppression by the mammalian Period genes. Cancer Causes Control 17 (2006) 525-530
68. Antoch M.P., et al. Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle 7 (2008) 1197-1204
69. Gorbacheva V.Y., et al. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3407-3412
70. Hoffman A.E., et al. The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol. Cancer Res. 6 (2008) 1461-1468
71. Yi, C. et al. (2009) The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer. Breast Cancer Res. Treat. (in press)
72. Ozturk N., et al. Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 2841-2846
73. Hoffman A.E., et al. Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res. 69 (2009) 3605-3613
74. Gamsby J.J., et al. A phylogenetically conserved DNA damage response resets the circadian clock. J. Biol. Rhythms 24 (2009) 193-202
75. Oklejewicz M., et al. Phase resetting of the mammalian circadian clock by DNA damage. Curr. Biol. 18 (2008) 286-291
76. Kuo S.J., et al. Disturbance of circadian gene expression in breast cancer. Virchows Arch. 454 (2009) 467-474
77. Lin Y.M., et al. Disturbance of circadian gene expression in hepatocellular carcinoma. Mol. Carcinog. 47 (2008) 925-933
78. Chen S.T., et al. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26 (2005) 1241-1246
79. Singletary J., et al. Imaging multidimensional therapeutically relevant circadian relationships. Int. J. Biomed. Imaging 2009 (2009) 231539
80. Nakagawa H., et al. Modulation of circadian rhythm of DNA synthesis in tumor cells by inhibiting platelet-derived growth factor signaling. J. Pharmacol. Sci. 107 (2008) 401-407
81. Filipski E., et al. Disruption of circadian coordination accelerates malignant growth in mice. Pathol. Biol. (Paris) 51 (2003) 216-219
82. Sephton S.E., et al. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer. Inst. 92 (2000) 994-1000
83. Mormont M.C., et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin. Cancer Res. 6 (2000) 3038-3045
84. Innominato P.F., et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 69 (2009) 4700-4707
85. Megdal S.P., et al. Night work and breast cancer risk: a systematic review and meta-analysis. Eur. J. Cancer 41 (2005) 2023-2032
86. Marino J.L., et al. Shift work, hCLOCK T3111C polymorphism, and endometriosis risk. Epidemiology 19 (2008) 477-484
87. Mormont M.C., and Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer 97 (2003) 155-169
88. Kang T.H., et al. Circadian oscillation of nucleotide excision repair in mammalian brain. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 2864-2867
89. Lim F.L., et al. Emerging evidence for the interrelationship of xenobiotic exposure and circadian rhythms: a review. Xenobiotica 36 (2006) 1140-1151
90. Levi F. Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control 17 (2006) 611-621
91. Giacchetti S., et al. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group. J. Clin. Oncol. 24 (2006) 3562-3569
92. Iurisci I., et al. Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res. 66 (2006) 10720-10728
93. Iurisci I., et al. Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib. Chronobiol. Int. 26 (2009) 1169-1188
94. Hatfield C.F., et al. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 127 (2004) 1061-1074
95. Hu K., et al. Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: Involvement of the circadian pacemaker. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 2490-2494
96. van Someren E.J.W., et al. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol. Psychiatry 38 (1995) 1-12
97. Kondratov R.V., et al. Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev. 20 (2006) 1868-1873
98. Sun Y., et al. The mortality of MOP3 deficient mice with a systemic functional failure. J. Biomed. Sci. 13 (2006) 845-851
99. Shimokawa I., et al. Longevity genes: insights from calorie restriction and genetic longevity models. Mol. Cells 26 (2008) 427-435
100. Rutter J., et al. Metabolism and the control of circadian rhythms. Annu. Rev. Biochem. 71 (2002) 307-331
101. Rutter J., et al. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science 293 (2001) 510-514
102. Yang J., et al. A novel heme-regulatory motif mediates heme-dependent degradation of the circadian factor period 2. Mol. Cell. Biol. 28 (2008) 4697-4711
103. Yin L., et al. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 318 (2007) 1786-1789
104. Ramsey K.M., et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324 (2009) 651-654
105. Nakahata Y., et al. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324 (2009) 654-657
106. +-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134 (2008) 329-340
107. Asher G., et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134 (2008) 317-328
108. Kim E.J., and Um S.J. SIRT1: roles in aging and cancer. BMB Rep. 41 (2008) 751-756
109. Anderson K.N., et al. Disrupted sleep and circadian patterns in frontotemporal dementia. Eur. J. Neurol. 16 (2009) 317-323
110. Morton A.J., et al. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J. Neurosci. 25 (2005) 157-163
111. Pallier P.N., et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J. Neurosci. 27 (2007) 7869-7878
112. Pallier P.N., and Morton A.J. Management of sleep/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease. Brain Res. 1279 (2009) 90-98
113. Yu B.H., Cho D.Y., and Jeong D.U. The effects of circadian rhythm in subjective alertness on the occurrence of traffic accidents. Sleep Med. Psychophysiol. 1 (1994) 68-75
114. Hastings M.H., et al. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat. Rev. Neurosci. 4 (2003) 649-661
115. Gallego M., and Virshup D.M. Post-translational modifications regulate the ticking of the circadian clock. Nat. Rev. Mol. Cell Biol. 8 (2007) 139-148
116. Preitner N., et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110 (2002) 251-260
117. Panda S., et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109 (2002) 307-320
118. Storch K.F., et al. Extensive and divergent circadian gene expression in liver and heart. Nature 417 (2002) 78-83
119. Cheng H.Y., et al. microRNA modulation of circadian-clock period and entrainment. Neuron 54 (2007) 813-829
120. Gatfield D., et al. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev. 23 (2009) 1313-1326
121. Dibner C., et al. Circadian gene expression is resilient to large fluctuations in overall transcription rates. EMBO J. 28 (2009) 123-134
122. Hastings M.H., et al. Cellular circadian pacemaking and the role of cytosolic rhythms. Curr. Biol. 18 (2008) R805-R815